fda warning letters compounded semaglutide tirzepatide 2024 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and "kits" π¨ FDA Moves to Permanently
Description
Wegovy or Zepbound
This product contains: 1-Db Goddess
By binding to brain receptors that regulate hunger and appetite, GLP-1 can help alter food preferences and reduce calorie consumption
Drug interactions dont come to the top of my mind when I see GLP-1 agonists in use
My latest for CNBC discusses how these new pills may not boost employer coverage.
Marine Collagen (Fish)
